Orthonotes
Orthonotes
by the.bonestories
v3.0 Fusion
v3.0 Fusion
Home Feed How to Use?
Learn
MCQs Wiki Cases DNB Ortho PYQs Analysis Resources BoneStories Live
Tools
Atlas Fracture Atlas Evidence
Guest
Login Register

Evidence Search

Search reputable indexed orthopaedic literature from multiple scholarly sources, classify the evidence, and link papers directly to wiki topics and cases.

Sources: PubMed, Europe PMC, Crossref

Linking results to Wiki: Chondrosarcoma
Reset
Results are classified automatically from source metadata across PubMed, Europe PMC, and Crossref.
PubMed Crossref
PubMed Guideline / Consensus Evidence High

Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology Meeting.

The bone & joint journal | 2025 | Jeys LM, Morris GV, Kurisunkal VJ, Botello E

[Indexed for MEDLINE] Conflict of interest statement: L. M. Jeys reports royalties or licenses from Implantcast, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Implantcast, Zimmer Biomet, and Stryker, and support for attending meetings and/or travel from Implantcast, all of which are unrelated to this study. G....

Open In Orthonotes
PubMed Guideline / Consensus Evidence High

Bone sarcomas and cancer predisposition syndromes.

Bulletin du cancer | 2025 | Tlemsani C, Bougeard G, Gauthier-Villars M, Denizeau P

[Indexed for MEDLINE] 8. FP Essent. 2020 Jun;493:22-26. Bone Tumors: Primary Bone Cancers. Keil L(1). Author information: (1)UNC Orthopaedics, 130 Mason Farm Road CB# 7055, Chapel Hill, NC 27599-7055. The three most common primary bone cancers are osteosarcoma, Ewing sarcoma, and chondrosarcoma. Osteosarcoma occurs most often in children and young adults, with a peak incidence...

Open In Orthonotes
PubMed Guideline / Consensus Evidence High

Controversies in orthopaedic oncology.

The bone & joint journal | 2024 | Jeys LM, Thorkildsen J, Kurisunkal V, Puri A

[Indexed for MEDLINE] Conflict of interest statement: A. Puri is a member of the editorial board of The Bone & Joint Journal. P. Ruggieri reports consulting fees from Exactech and Stryker, unrelated to this study. M. T. Houdek reports consulting fees from Link Orthopedics, unrelated to this study. E. Botello reports consulting fees, payment or honoraria for lectures, presentati...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Molecular and immunohistochemical testing of bone tumours: review and update.

Histopathology | 2023 | Kovacs SK, Manassaporn A, Nielsen GP, Hung YP

[Indexed for MEDLINE] 10. Neuroendocrinology. 2020;110(9-10):836-847. doi: 10.1159/000509386. Epub 2020 Jun 15. Skull Base Chordomas and Chondrosarcomas. Kremenevski N(1), Schlaffer SM(2), Coras R(3), Kinfe TM(2), Graillon T(4), Buchfelder M(2). Author information: (1)Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany, natalia.kremenevskaja@uk-erlang...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.

International journal of molecular sciences | 2023 | Tlemsani C, Larousserie F, De Percin S, Audard V

[Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest. 15. Oncologist. 2008 Mar;13(3):320-9. doi: 10.1634/theoncologist.2007-0237. The clinical approach towards chondrosarcoma. Gelderblom H(1), Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV. Author information: (1)Department of Clinical Oncology (Medical O...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Skull Base Chordomas and Chondrosarcomas.

Neuroendocrinology | 2020 | Kremenevski N, Schlaffer SM, Coras R, Kinfe TM

[Indexed for MEDLINE] 11. Future Oncol. 2017 Mar;13(7):637-648. doi: 10.2217/fon-2016-0226. Epub 2017 Jan 30. Novel therapeutic approaches in chondrosarcoma. Polychronidou G(1), Karavasilis V(1), Pollack SM(2), Huang PH(3), Lee A(4), Jones RL(4)(5). Author information: (1)London Sarcoma Service, University College London Hospital, London, UK. (2)Fred Hutchinson Cancer Research...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Chondrosarcoma: biology, genetics, and epigenetics.

F1000Research | 2018 | Chow WA

[Indexed for MEDLINE] Conflict of interest statement: No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed. 6. Orthopadie (Heidelb). 2023 Jun;52(6):509-522. doi: 10.1007/s00132-023-04387-1. Epub 2023 Jun 6. [Primary malignant bone tumors]. [Article in German; Abstract available in German from the publisher] Funovics P...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Novel therapeutic approaches in chondrosarcoma.

Future oncology (London, England) | 2017 | Polychronidou G, Karavasilis V, Pollack SM, Huang PH

[Indexed for MEDLINE] 12. Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2601-9. doi: 10.1007/s00405-013-2807-3. Epub 2013 Nov 10. Chondrosarcomas of the head and neck. Coca-Pelaz A(1), Rodrigo JP, Triantafyllou A, Hunt JL, Fernández-Miranda JC, Strojan P, de Bree R, Rinaldo A, Takes RP, Ferlito A. Author information: (1)Department of Otolaryngology, Hospital Universitario Central...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Chondrosarcomas of the head and neck.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2014 | Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL

[Indexed for MEDLINE] 13. Genes Chromosomes Cancer. 2025 Sep;64(9):e70068. doi: 10.1002/gcc.70068. BCOR-Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study. Montoya-Cerrillo DM(1), Evans MG(2), Elliott A(2), Anyosa RC(3), Torres JV(1), Montgomery EA(1), Hornicek FJ(4), Temple HT(4), Crawford B(4), Trent J(5), Jonczak EE(5), D'Amato G(5), Rosenber...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

BCOR-Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study.

Genes, chromosomes & cancer | 2025 | Montoya-Cerrillo DM, Evans MG, Elliott A, Anyosa RC

[Indexed for MEDLINE] 14. Int J Mol Sci. 2023 Jan 10;24(2):1361. doi: 10.3390/ijms24021361. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. Tlemsani C(1)(2), Larousserie F(3), De Percin S(1), Audard V(3), Hadjadj D(2), Chen J(1), Biau D(4), Anract P(4), Terris B(3), Goldwasser F(1), Pasmant E(2)(5), Boudou-Rouquette P(1)(2). Auth...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2025 | Meijer DM, Venneker S, Ameline B, Erdem Z

[Indexed for MEDLINE] 17. Expert Rev Mol Diagn. 2002 Sep;2(5):461-72. doi: 10.1586/14737159.2.5.461. Diagnosis and prognosis of chondrosarcoma of bone. Rozeman LB(1), Hogendoorn PC, Bovée JV. Author information: (1)Department of Pathology, Leiden University Medical Center, P O Box 9600, NL-2300 RC Leiden, The Netherlands. L.B.Rozeman@lumc.nl The mechanisms of chondrosarcoma dev...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

Grading chondroid tumors through MRI radiomics: enchondroma, low-grade chondrosarcoma and higher-grade chondrosarcoma.

BMC cancer | 2025 | Park H, Lee J, Lee S, Jung JY

[Indexed for MEDLINE] Conflict of interest statement: Declarations. Ethics approval and consent to participate: All procedures performed in this study were conducted in accordance with relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki. The institutional review board of Seoul St.Mary’s Hospital, The Catholic University of Korea...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

[Primary malignant bone tumors].

Orthopadie (Heidelberg, Germany) | 2023 | Funovics PT

[Indexed for MEDLINE] 7. Bull Cancer. 2025 Jun;112(6):664-680. doi: 10.1016/j.bulcan.2024.10.014. Epub 2025 Jan 22. Bone sarcomas and cancer predisposition syndromes. Tlemsani C(1), Bougeard G(2), Gauthier-Villars M(3), Denizeau P(4), Winter S(5), Michot C(6), Baujat G(6), Bressac B(7), Adam de Beaumais T(8), Rouchaud A(9), Mihoubi-Bouvier F(10), Bourdeaut F(5), Brugières L(11)...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

The clinical approach towards chondrosarcoma.

The oncologist | 2008 | Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS

[Indexed for MEDLINE] 16. Mod Pathol. 2025 Dec;38(12):100894. doi: 10.1016/j.modpat.2025.100894. Epub 2025 Sep 19. An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma. Meijer DM(1), Venneker S(2), Ameline B(3), Erdem Z(2), Cardoso S(1), Ruano D(2), Briaire-de Bruijn IH(2), van den Akker BE(2), Wijers-Koster PM(2), Scholte CHJ(4), van Praag VM...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Update on chondrosarcomas.

Current opinion in oncology | 2007 | Chow WA

[Indexed for MEDLINE] 4. Bone Joint J. 2024 May 1;106-B(5):425-429. doi: 10.1302/0301-620X.106B5.BJJ-2023-1381. Controversies in orthopaedic oncology. Jeys LM(1), Thorkildsen J(2), Kurisunkal V(1), Puri A(3), Ruggieri P(4), Houdek MT(5), Boyle RA(6), Ebeid W(7), Botello E(8), Morris GV(1); BOOM Consensus Scientific Committee; Laitinen MK(140); BOOM Consensus Scientific Committe...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

Bone Tumors: Primary Bone Cancers.

FP essentials | 2020 | Keil L

[Indexed for MEDLINE] 9. Histopathology. 2023 May;82(6):794-811. doi: 10.1111/his.14845. Epub 2022 Dec 16. Molecular and immunohistochemical testing of bone tumours: review and update. Kovacs SK(1), Manassaporn A(1), Nielsen GP(1), Hung YP(1). Author information: (1)Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Primary bone...

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Diagnosis and prognosis of chondrosarcoma of bone.

Expert review of molecular diagnostics | 2002 | Rozeman LB, Hogendoorn PC, Bovée JV

[Indexed for MEDLINE] 18. J Am Acad Orthop Surg. 2000 Sep-Oct;8(5):292-304. doi: 10.5435/00124635-200009000-00003. Cartilage tumors: evaluation and treatment. Marco RA(1), Gitelis S, Brebach GT, Healey JH. Author information: (1)M.D. Anderson Cancer Center, Houston, USA. The proper treatment of cartilaginous tumors is dependent on the clinicopathologic and radiologic findings....

Open In Orthonotes
PubMed Narrative Review Evidence Moderate

Cartilage tumors: evaluation and treatment.

The Journal of the American Academy of Orthopaedic Surgeons | 2000 | Marco RA, Gitelis S, Brebach GT, Healey JH

[Indexed for MEDLINE] 19. BMC Cancer. 2025 May 22;25(1):918. doi: 10.1186/s12885-025-14330-6. Grading chondroid tumors through MRI radiomics: enchondroma, low-grade chondrosarcoma and higher-grade chondrosarcoma. Park H(1), Lee J(2), Lee S(3), Jung JY(4). Author information: (1)Department of Radiology, College of Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyan...

Open In Orthonotes
PubMed Original Article Evidence Unclassified

Chondrosarcomas revisited.

Orthopedics | 2012 | Mavrogenis AF, Gambarotti M, Angelini A, Palmerini E

[Indexed for MEDLINE] 3. Curr Opin Oncol. 2007 Jul;19(4):371-6. doi: 10.1097/CCO.0b013e32812143d9. Update on chondrosarcomas. Chow WA(1). Author information: (1)City of Hope Medical Center, Division of Medical Oncology & Therapeutics Research, Duarte, CA 91010, USA. wchow@coh.org PURPOSE OF REVIEW: This paper reviews recent molecular, biologic, developmental therapeutic, and cl...

Open In Orthonotes